|
KMID : 0391019940020020112
|
|
Journal of Korean Society for Clinical Pharmacology and Therapeutics
1994 Volume.2 No. 2 p.112 ~ p.117
|
|
|
Anti-Cancer Drg Development in Japan
|
|
Samyong Kim
|
|
|
Abstract
|
|
|
This survey is a sketchy description on anticancer drug development in Japan mainly
focusing on preclinical development and phase I clinical trials.
Anticancer drug hunting in Japan is mainly pursued in pharmaceutical companies and
the results are quite impressive. Several companies in Japan have keen successful in
developing many kinds of DNA-reacting anti-cancer agents like Mitomycin-C and it’s
derivatives.
|
|
|
KEYWORD
|
|
|
|
|
|
FullTexts / Linksout information
|
|
 
|
|
|
Listed journal information
|
|
 
|